Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Covid-19 Omicron”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05328479
What this trial is testing

Plasma Immunity of Mild SARS-CoV-2 Omicron and Delta Pandemic in Thailand

Who this might be right for
COVID-19
Mahidol University 5,181
Large-scale testing (Phase 3)UnknownNCT05308576
What this trial is testing

Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 10,000
Large-scale testing (Phase 3)UnknownNCT05749926
What this trial is testing

Immunogenicity and Reactogenicity of the Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine

Who this might be right for
Vaccine ReactionCOVID-19
Assistance Publique - Hôpitaux de Paris 248
Testing effectiveness (Phase 2)UnknownNCT05345873
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 300
Large-scale testing (Phase 3)UnknownNCT05636319
What this trial is testing

Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Variant (BA.4 /5) mRNA Vaccine

Who this might be right for
COVID-19
Suzhou Abogen Biosciences Co., Ltd. 14,168
Early research (Phase 1)UnknownNCT05433194
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19 Omicron) mRNA Vaccine (Phase 1)

Who this might be right for
COVID-19
Suzhou Abogen Biosciences Co., Ltd. 48
Testing effectiveness (Phase 2)Study completedNCT05411471
What this trial is testing

Immunogenicity and Safety Study of Booster Vaccine With the COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain

Who this might be right for
COVID-19
Sinovac Biotech (Hong Kong) Limited 221
Early research (Phase 1)Active Not RecruitingNCT06478420
What this trial is testing

COVID-19 Omicron BA.5 Subvariant Dose Finding Infection Study

Who this might be right for
SARS-CoV-2 Infection
University of Oxford 45
Large-scale testing (Phase 3)UnknownNCT05230953
What this trial is testing

Fourth COVID-19 Vaccine Dose- mRNA1273

Who this might be right for
COVID-19 Pandemic
Sheba Medical Center 1,000
Not applicableUnknownNCT05379543
What this trial is testing

Echocardiographic Manifestation in Patients With Omicron Variant of COVID-19

Who this might be right for
COVID-19
RenJi Hospital 200
Early research (Phase 1)Looking for participantsNCT07397455
What this trial is testing

Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron Subvariants

Who this might be right for
SARS-CoV-2 (COVID-19)
Imperial College London 38
Large-scale testing (Phase 3)UnknownNCT05616754
What this trial is testing

A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell)

Who this might be right for
COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 400
Testing effectiveness (Phase 2)Study completedNCT05383560
What this trial is testing

Safety and Immunogenicity of Omicron Variant-Matched Vaccine Booster in Adults

Who this might be right for
COVID-19 PandemicImmunogenicitySARS CoV 2 Infection+1 more
Sheba Medical Center 179
Not applicableStudy completedNCT05175690
What this trial is testing

Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness

Who this might be right for
COVID19
AudibleHealth AI, Inc. 1,126
Large-scale testing (Phase 3)Study completedNCT05372588
What this trial is testing

Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines

Who this might be right for
COVID-19SARS CoV 2 Infection
Novavax 1,340
Not applicableUnknownNCT05745545
What this trial is testing

Clinical Trial of COVID-19 Vaccine（SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine） in Participants Aged 18 Years and Over

Who this might be right for
SARS-CoV-2
AIM Vaccine Co., Ltd. 3,200
Testing effectiveness (Phase 2)WithdrawnNCT05308602
What this trial is testing

Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E (Two Recombinant Protein COVID-19 Vaccines) in Population Aged ≥12 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd.
Large-scale testing (Phase 3)Study completedNCT05975060
What this trial is testing

Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.

Who this might be right for
COVID-19
Novavax 660
Post-approval studies (Phase 4)UnknownNCT05231005
What this trial is testing

Fourth BNT162b2 COVID-19 Vaccine Dose

Who this might be right for
COVID-19 Pandemic
Sheba Medical Center 1,000
Testing effectiveness (Phase 2)UnknownNCT05930730
What this trial is testing

Immunogenicity and Safety of Comvigen (Bivalent) Vaccine

Who this might be right for
Safety of a Single Dose of COMVIGEN VaccineReactogenicity of a Single Dose of COMVIGEN VaccineImmunogenicity of a Single Dose of COMVIGEN Vaccine+3 more
Chulalongkorn University 450
Next Page